{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:19:30Z","timestamp":1790777970004,"version":"4.1.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001023","name":"Australian Institute of Nuclear Science and Engineering","doi-asserted-by":"publisher","award":["ALNSTU12810"],"award-info":[{"award-number":["ALNSTU12810"]}],"id":[{"id":"10.13039\/501100001023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001043","name":"Cass Foundation","doi-asserted-by":"publisher","award":["10021"],"award-info":[{"award-number":["10021"]}],"id":[{"id":"10.13039\/501100001043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1154270"],"award-info":[{"award-number":["GNT1154270"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Nanotechnol."],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1038\/s41565-022-01270-6","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T17:31:45Z","timestamp":1671471105000},"page":"11-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The potential impact of nanomedicine on COVID-19-induced thrombosis"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2918-407X","authenticated-orcid":false,"given":"Peije","family":"Russell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7114-4023","authenticated-orcid":false,"given":"Christoph E.","family":"Hagemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1536-7804","authenticated-orcid":false,"given":"Nicolas H.","family":"Voelcker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"1270_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533\u2013534 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"1270_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M20-2003","volume":"173","author":"D Wichmann","year":"2020","unstructured":"Wichmann, D. et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann. Intern. Med. 173, 268\u2013277 (2020).","journal-title":"Ann. Intern. Med."},{"key":"1270_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok, F. A. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb. Res. 191, 148\u2013150 (2020).","journal-title":"Thromb. Res."},{"key":"1270_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583\u2013590 (2022).","journal-title":"Nat. Med."},{"key":"1270_CR5","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani, S. S. et al. Heart disease and stroke statistics\u20142021 update. Circulation 143, e254\u2013e743 (2021).","journal-title":"Circulation"},{"key":"1270_CR6","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/S0735-1097(21)03182-X","volume":"77","author":"T Wilcox","year":"2021","unstructured":"Wilcox, T., Smilowitz, N. & Berger, J. Age and sex differences in incident thrombosis in patients hospitalized with COVID-19. J. Am. Coll. Cardiol. 77, 1826 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1270_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.14336\/AD.2021.0704","volume":"13","author":"A-T Chen","year":"2022","unstructured":"Chen, A.-T., Wang, C.-Y., Zhu, W.-L. & Chen, W. Coagulation disorders and thrombosis in COVID-19 patients and a possible mechanism involving endothelial cells: a review. Aging Dis. 13, 144\u2013156 (2022).","journal-title":"Aging Dis."},{"key":"1270_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12959-022-00375-1","volume":"20","author":"M Behzadifard","year":"2022","unstructured":"Behzadifard, M. & Soleimani, M. NETosis and SARS-COV-2 infection related thrombosis: a narrative review. Thromb. J. 20, 13 (2022).","journal-title":"Thromb. J."},{"key":"1270_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1515\/cclm-2021-0108","volume":"59","author":"E Campello","year":"2021","unstructured":"Campello, E. et al. Thrombin generation in patients with COVID-19 with and without thromboprophylaxis. Clin. Chem. Lab. Med. 59, 1323\u20131330 (2021).","journal-title":"Clin. Chem. Lab. Med."},{"key":"1270_CR10","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1172\/JCI141374","volume":"130","author":"P Skendros","year":"2020","unstructured":"Skendros, P. et al. Complement and tissue factor\u2013enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J. Clin. Investig. 130, 6151\u20136157 (2020).","journal-title":"J. Clin. Investig."},{"key":"1270_CR11","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","volume":"7","author":"G Goshua","year":"2020","unstructured":"Goshua, G. et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 7, e575\u2013e582 (2020).","journal-title":"Lancet Haematol."},{"key":"1270_CR12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2020","unstructured":"Thachil, J. et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J. Thromb. Haemost. 18, 1023\u20131026 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"1270_CR13","doi-asserted-by":"publisher","first-page":"n2400","DOI":"10.1136\/bmj.n2400","volume":"375","author":"M Sholzberg","year":"2021","unstructured":"Sholzberg, M. et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with COVID-19 admitted to hospital: RAPID randomised clinical trial. Brit. Med. J. 375, n2400 (2021).","journal-title":"Brit. Med. J."},{"key":"1270_CR14","doi-asserted-by":"crossref","unstructured":"The REMAP-CAP, ACTIV-4a & ATTACC Investigators Therapeutic anticoagulation with heparin in critically ill patients with COVID-19. N. Engl. J. Med. 385, 777\u2013789 (2021)..","DOI":"10.1056\/NEJMoa2103417"},{"key":"1270_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-0-12-394309-5.00006-7","volume":"298","author":"T Kalogeris","year":"2012","unstructured":"Kalogeris, T., Baines, C. P., Krenz, M. & Korthuis, R. J. Cell biology of ischemia\/reperfusion injury. Int. Rev. Cell Mol. Biol. 298, 229\u2013317 (2012).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"1270_CR16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/17434440.2020.1784004","volume":"17","author":"R Blanc","year":"2020","unstructured":"Blanc, R. et al. Recent advances in devices for mechanical thrombectomy. Expert Rev. Med. Devices 17, 697\u2013706 (2020).","journal-title":"Expert Rev. Med. Devices"},{"key":"1270_CR17","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/jth.14872","volume":"18","author":"CS Whyte","year":"2020","unstructured":"Whyte, C. S., Morrow, G. B., Mitchell, J. L., Chowdary, P. & Mutch, N. J. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J. Thromb. Haemost. 18, 1548\u20131555 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"1270_CR18","first-page":"186","volume":"51","author":"EY Ucar","year":"2019","unstructured":"Ucar, E. Y. Update on thrombolytic therapy in acute pulmonary thromboembolism. Eurasian J. Med. 51, 186\u2013190 (2019).","journal-title":"Eurasian J. Med."},{"key":"1270_CR19","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1161\/STROKEAHA.120.029749","volume":"51","author":"SJ Warach","year":"2020","unstructured":"Warach, S. J., Dula, A. N. & Milling, T. J. Tenecteplase thrombolysis for acute ischemic stroke. Stroke 51, 3440\u20133451 (2020).","journal-title":"Stroke"},{"key":"1270_CR20","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1111\/jth.14828","volume":"18","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. J. Thromb. Haemost. 18, 1752\u20131755 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"1270_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijid.2020.12.043","volume":"104","author":"D Kosanovic","year":"2021","unstructured":"Kosanovic, D. et al. Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale. Int. J. Infect. Dis. 104, 108\u2013110 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"1270_CR22","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.chest.2021.09.024","volume":"161","author":"CD Barrett","year":"2022","unstructured":"Barrett, C. D. et al. Study of alteplase for respiratory failure in SARS-CoV-2 COVID-19: a vanguard multicenter, rapidly adaptive, pragmatic, randomized controlled trial. Chest 161, 710\u2013727 (2022).","journal-title":"Chest"},{"key":"1270_CR23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/ccd.28042","volume":"93","author":"DP Rothschild","year":"2019","unstructured":"Rothschild, D. P., Goldstein, J. A. & Bowers, T. R. Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: clinical efficacy but attendant hemorrhagic risks. Catheter. Cardiovasc. Interv. 93, 506\u2013510 (2019).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"1270_CR24","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41565-022-01174-5","volume":"17","author":"X Huang","year":"2022","unstructured":"Huang, X. et al. Nanotechnology-based strategies against SARS-CoV-2 variants. Nat. Nanotechnol. 17, 1027\u20131037 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"1270_CR25","doi-asserted-by":"publisher","first-page":"12224","DOI":"10.1021\/acsnano.8b06021","volume":"12","author":"M Colasuonno","year":"2018","unstructured":"Colasuonno, M. et al. Erythrocyte-inspired discoidal polymeric nanoconstructs carrying tissue plasminogen activator for the enhanced lysis of blood clots. ACS Nano 12, 12224\u201312237 (2018).","journal-title":"ACS Nano"},{"key":"1270_CR26","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1021\/acsnano.9b01798","volume":"13","author":"J Xu","year":"2019","unstructured":"Xu, J. et al. Sequentially site-specific delivery of thrombolytics and neuroprotectant for enhanced treatment of ischemic stroke. ACS Nano 13, 8577\u20138588 (2019).","journal-title":"ACS Nano"},{"key":"1270_CR27","doi-asserted-by":"publisher","first-page":"1905145","DOI":"10.1002\/adma.201905145","volume":"32","author":"J Xu","year":"2020","unstructured":"Xu, J. et al. Engineered nanoplatelets for targeted delivery of plasminogen activators to reverse thrombus in multiple mouse thrombosis models. Adv. Mater. 32, 1905145 (2020).","journal-title":"Adv. Mater."},{"key":"1270_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jconrel.2017.11.007","volume":"269","author":"LM Russell","year":"2018","unstructured":"Russell, L. M., Hultz, M. & Searson, P. C. Leakage kinetics of the liposomal chemotherapeutic agent doxil: the role of dissolution, protonation, and passive transport, and implications for mechanism of action. J. Control. Release 269, 171\u2013176 (2018).","journal-title":"J. Control. Release"},{"key":"1270_CR29","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1016\/j.biomaterials.2009.07.021","volume":"30","author":"J-Y Kim","year":"2009","unstructured":"Kim, J.-Y., Kim, J.-K., Park, J.-S., Byun, Y. & Kim, C.-K. The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator. Biomaterials 30, 5751\u20135756 (2009).","journal-title":"Biomaterials"},{"key":"1270_CR30","doi-asserted-by":"publisher","first-page":"2003937","DOI":"10.1002\/advs.202003937","volume":"8","author":"W Zhang","year":"2021","unstructured":"Zhang, W., Mehta, A., Tong, Z., Esser, L. & Voelcker, N. H. Development of polymeric nanoparticles for blood\u2013brain barrier transfer\u2014strategies and challenges. Adv. Sci. 8, 2003937 (2021).","journal-title":"Adv. Sci."},{"key":"1270_CR31","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1039\/C9MH01669D","volume":"7","author":"S Matoori","year":"2020","unstructured":"Matoori, S. & Leroux, J.-C. Twenty-five years of polymersomes: lost in translation? Mater. Horiz. 7, 1297\u20131309 (2020).","journal-title":"Mater. Horiz."},{"key":"1270_CR32","doi-asserted-by":"publisher","first-page":"1701824","DOI":"10.1002\/adfm.201701824","volume":"27","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. Near-infrared triggered release of uPA from nanospheres for localized hyperthermia-enhanced thrombolysis. Adv. Funct. Mater. 27, 1701824 (2017).","journal-title":"Adv. Funct. Mater."},{"key":"1270_CR33","doi-asserted-by":"publisher","first-page":"eaaz8204","DOI":"10.1126\/sciadv.aaz8204","volume":"6","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles. Sci. Adv. 6, eaaz8204 (2020).","journal-title":"Sci. Adv."},{"key":"1270_CR34","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/adfm.201404354","volume":"25","author":"E Voros","year":"2015","unstructured":"Voros, E. et al. TPA immobilization on iron oxide nanocubes and localized magnetic hyperthermia accelerate blood clot lysis. Adv. Funct. Mater. 25, 1709\u20131718 (2015).","journal-title":"Adv. Funct. Mater."},{"key":"1270_CR35","doi-asserted-by":"publisher","first-page":"1805730","DOI":"10.1002\/adma.201805730","volume":"31","author":"G Yang","year":"2019","unstructured":"Yang, G., Phua, S. Z. F., Bindra, A. K. & Zhao, Y. Degradability and clearance of inorganic nanoparticles for biomedical applications. Adv. Mater. 31, 1805730 (2019).","journal-title":"Adv. Mater."},{"key":"1270_CR36","doi-asserted-by":"publisher","first-page":"14958","DOI":"10.1021\/acsami.0c01768","volume":"12","author":"K Chen","year":"2020","unstructured":"Chen, K. et al. Intrinsic biotaxi solution based on blood cell membrane cloaking enables fullerenol thrombolysis in vivo. ACS Appl. Mater. Interfaces 12, 14958\u201314970 (2020).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"1270_CR37","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jconrel.2020.10.020","volume":"329","author":"J Wang","year":"2021","unstructured":"Wang, J., Chen, D. & Ho, E. A. Challenges in the development and establishment of exosome-based drug delivery systems. J. Control. Release 329, 894\u2013906 (2021).","journal-title":"J. Control. Release"},{"key":"1270_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/biom11020317","volume":"11","author":"H Kang","year":"2021","unstructured":"Kang, H., Seo, J., Yang, E.-J. & Choi, I.-H. Silver nanoparticles induce neutrophil extracellular traps via activation of PAD and neutrophil elastase. Biomolecules 11, 317 (2021).","journal-title":"Biomolecules"},{"key":"1270_CR39","doi-asserted-by":"publisher","first-page":"111900","DOI":"10.1016\/j.ecoenv.2021.111900","volume":"211","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. Gold nanoparticles synergize with bacterial lipopolysaccharide to enhance class A scavenger receptor dependent particle uptake in neutrophils and augment neutrophil extracellular traps formation. Ecotoxicol. Environ. Saf. 211, 111900 (2021).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"1270_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1021\/nl902830x","volume":"10","author":"M Bartneck","year":"2010","unstructured":"Bartneck, M., Keul, H. A., Zwadlo-Klarwasser, G. & Groll, J. Phagocytosis independent extracellular nanoparticle clearance by human immune cells. Nano Lett. 10, 59\u201363 (2010).","journal-title":"Nano Lett."},{"key":"1270_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/bios12020123","volume":"12","author":"HT Snoderly","year":"2022","unstructured":"Snoderly, H. T. et al. PEGylation of metal oxide nanoparticles modulates neutrophil extracellular trap formation. Biosensors 12, 123 (2022).","journal-title":"Biosensors"},{"key":"1270_CR42","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.3389\/fimmu.2018.02266","volume":"9","author":"R Bilyy","year":"2018","unstructured":"Bilyy, R. et al. Inert coats of magnetic nanoparticles prevent formation of occlusive intravascular co-aggregates with neutrophil extracellular traps. Front. Immunol. 9, 2266 (2018).","journal-title":"Front. Immunol."},{"key":"1270_CR43","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1039\/C7NR03552G","volume":"10","author":"SP Mukherjee","year":"2018","unstructured":"Mukherjee, S. P. et al. Graphene oxide is degraded by neutrophils and the degradation products are non-genotoxic. Nanoscale 10, 1180\u20131188 (2018).","journal-title":"Nanoscale"},{"key":"1270_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cbi.2015.04.011","volume":"235","author":"T-L Hwang","year":"2015","unstructured":"Hwang, T.-L., Aljuffali, I. A., Hung, C.-F., Chen, C.-H. & Fang, J.-Y. The impact of cationic solid lipid nanoparticles on human neutrophil activation and formation of neutrophil extracellular traps (NETs). Chem. Biol. Interact. 235, 106\u2013114 (2015).","journal-title":"Chem. Biol. Interact."},{"key":"1270_CR45","doi-asserted-by":"publisher","first-page":"E5856","DOI":"10.1073\/pnas.1602230113","volume":"113","author":"LE Mu\u00f1oz","year":"2016","unstructured":"Mu\u00f1oz, L. E. et al. Nanoparticles size-dependently initiate self-limiting NETosis-driven inflammation. Proc. Natl Acad. Sci. USA 113, E5856\u2013E5865 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1270_CR46","doi-asserted-by":"publisher","first-page":"3560180","DOI":"10.1155\/2019\/3560180","volume":"2019","author":"H Yang","year":"2019","unstructured":"Yang, H. et al. Nanomaterial exposure induced neutrophil extracellular traps: a new target in inflammation and innate immunity. J. Immunol. Res. 2019, 3560180 (2019).","journal-title":"J. Immunol. Res."},{"key":"1270_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2009.12.019","volume":"143","author":"HL Kutscher","year":"2010","unstructured":"Kutscher, H. L. et al. Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats. J. Control. Release 143, 31\u201337 (2010).","journal-title":"J. Control. Release"},{"key":"1270_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1021\/jacs.6b12297","volume":"139","author":"LM Herda","year":"2017","unstructured":"Herda, L. M., Hristov, D. R., Lo Giudice, M. C., Polo, E. & Dawson, K. A. Mapping of molecular structure of the nanoscale surface in bionanoparticles. J. Am. Chem. Soc. 139, 111\u2013114 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"1270_CR49","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41565-018-0246-4","volume":"13","author":"M Faria","year":"2018","unstructured":"Faria, M. et al. Minimum information reporting in bio-nano experimental literature. Nat. Nanotechnol. 13, 777\u2013785 (2018).","journal-title":"Nat. Nanotechnol."},{"key":"1270_CR50","doi-asserted-by":"publisher","first-page":"10287","DOI":"10.1021\/acsami.0c20940","volume":"13","author":"T-Y Lu","year":"2021","unstructured":"Lu, T.-Y. et al. Dual-targeting glycol chitosan\/heparin-decorated polypyrrole nanoparticle for augmented photothermal thrombolytic therapy. ACS Appl. Mater. Interfaces 13, 10287\u201310300 (2021).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"1270_CR51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbagen.2008.10.008","volume":"1790","author":"L Bachelet","year":"2009","unstructured":"Bachelet, L. et al. Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets. Biochim. Biophys. Acta 1790, 141\u2013146 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"1270_CR52","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.biomaterials.2017.11.047","volume":"156","author":"M Juenet","year":"2018","unstructured":"Juenet, M. et al. Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting P-selectin. Biomaterials 156, 204\u2013216 (2018).","journal-title":"Biomaterials"},{"key":"1270_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jconrel.2021.06.043","volume":"339","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Thrombus-targeted nanoparticles for thrombin-triggered thrombolysis and local inflammatory microenvironment regulation. J. Control. Release 339, 195\u2013207 (2021).","journal-title":"J. Control. Release"},{"key":"1270_CR54","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.actbio.2021.07.072","volume":"134","author":"L-H Chang","year":"2021","unstructured":"Chang, L.-H. et al. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent. Acta Biomater. 134, 686\u2013701 (2021).","journal-title":"Acta Biomater."},{"key":"1270_CR55","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/molecules26020430","volume":"26","author":"V Apostolopoulos","year":"2021","unstructured":"Apostolopoulos, V. et al. A global review on short peptides: frontiers and perspectives. Molecules 26, 430 (2021).","journal-title":"Molecules"},{"key":"1270_CR56","doi-asserted-by":"publisher","first-page":"21255","DOI":"10.1039\/D0NR03633A","volume":"12","author":"M Sun","year":"2020","unstructured":"Sun, M. et al. Combination targeting of \u2018platelets + fibrin\u2019 enhances clot anchorage efficiency of nanoparticles for vascular drug delivery. Nanoscale 12, 21255\u201321270 (2020).","journal-title":"Nanoscale"},{"key":"1270_CR57","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.biomaterials.2017.03.012","volume":"128","author":"CL Pawlowski","year":"2017","unstructured":"Pawlowski, C. L. et al. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis. Biomaterials 128, 94\u2013108 (2017).","journal-title":"Biomaterials"},{"key":"1270_CR58","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1039\/D0BM00917B","volume":"8","author":"A Yang","year":"2020","unstructured":"Yang, A. et al. Thrombin-responsive engineered nanoexcavator with full-thickness infiltration capability for pharmaceutical-free deep venous thrombosis theranostics. Biomater. Sci. 8, 4545\u20134558 (2020).","journal-title":"Biomater. Sci."},{"key":"1270_CR59","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2217\/nnm.11.21","volume":"6","author":"JN Marsh","year":"2011","unstructured":"Marsh, J. N. et al. A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke. Nanomedicine 6, 605\u2013615 (2011).","journal-title":"Nanomedicine"},{"key":"1270_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/01.RES.0000232317.84122.0c","volume":"99","author":"M Schwarz","year":"2006","unstructured":"Schwarz, M. et al. Conformation-specific blockade of the integrin GPIIb\/IIIa. Circ. Res. 99, 25\u201333 (2006).","journal-title":"Circ. Res."},{"key":"1270_CR61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/antib8020028","volume":"8","author":"A Bates","year":"2019","unstructured":"Bates, A. & Power, C. A. David vs. Goliath: the structure, function, and clinical prospects of antibody fragments. Antibodies 8, 28 (2019).","journal-title":"Antibodies"},{"key":"1270_CR62","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1021\/acsami.9b20993","volume":"12","author":"KW Yong","year":"2020","unstructured":"Yong, K. W., Yuen, D., Chen, M. Z. & Johnston, A. P. R. Engineering the orientation, density, and flexibility of single-domain antibodies on nanoparticles to improve cell targeting. ACS Appl. Mater. Interfaces 12, 5593\u20135600 (2020).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"1270_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","volume":"27","author":"R-M Lu","year":"2020","unstructured":"Lu, R.-M. et al. Development of therapeutic antibodies for the treatment of diseases. J. Biomed. Sci. 27, 1 (2020).","journal-title":"J. Biomed. Sci."},{"key":"1270_CR64","doi-asserted-by":"publisher","first-page":"100986","DOI":"10.1016\/j.nantod.2020.100986","volume":"35","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy. Nano Today 35, 100986 (2020).","journal-title":"Nano Today"},{"key":"1270_CR65","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s41565-022-01161-w","volume":"17","author":"MA Cruz","year":"2022","unstructured":"Cruz, M. A. et al. Nanomedicine platform for targeting activated neutrophils and neutrophil\u2013platelet complexes using an \u03b11-antitrypsin-derived peptide motif. Nat. Nanotechnol. 17, 1004\u20131014 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"1270_CR66","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1126\/science.1217815","volume":"337","author":"N Korin","year":"2012","unstructured":"Korin, N. et al. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science 337, 738\u2013742 (2012).","journal-title":"Science"},{"key":"1270_CR67","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1161\/STROKEAHA.115.011063","volume":"46","author":"MG Marosfoi","year":"2015","unstructured":"Marosfoi, M. G. et al. Shear-activated nanoparticle aggregates combined with temporary endovascular bypass to treat large vessel occlusion. Stroke 46, 3507\u20133513 (2015).","journal-title":"Stroke"},{"key":"1270_CR68","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1002\/adfm.201400279","volume":"24","author":"Y Wang","year":"2014","unstructured":"Wang, Y., Shim, M. S., Levinson, N. S., Sung, H.-W. & Xia, Y. Stimuli-responsive materials for controlled release of theranostic agents. Adv. Funct. Mater. 24, 4206\u20134220 (2014).","journal-title":"Adv. Funct. Mater."},{"key":"1270_CR69","doi-asserted-by":"publisher","first-page":"e149236","DOI":"10.1172\/JCI149236","volume":"131","author":"JM Snider","year":"2021","unstructured":"Snider, J. M. et al. Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality. J. Clin. Invest. 131, e149236 (2021).","journal-title":"J. Clin. Invest."},{"key":"1270_CR70","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1016\/j.ijcard.2013.07.154","volume":"168","author":"S Takahashi","year":"2013","unstructured":"Takahashi, S. et al. Phospholipase A2 expression in coronary thrombus is increased in patients with recurrent cardiac events after acute myocardial infarction. Int. J. Cardiol. 168, 4214\u20134221 (2013).","journal-title":"Int. J. Cardiol."},{"key":"1270_CR71","doi-asserted-by":"publisher","first-page":"e31756","DOI":"10.1371\/journal.pone.0031756","volume":"7","author":"M Gallwitz","year":"2012","unstructured":"Gallwitz, M., Enoksson, M., Thorpe, M. & Hellman, L. The extended cleavage specificity of human thrombin. PLoS ONE 7, e31756 (2012).","journal-title":"PLoS ONE"},{"key":"1270_CR72","doi-asserted-by":"publisher","first-page":"s11","DOI":"10.1161\/ATVBAHA.107.159178","volume":"28","author":"JE Freedman","year":"2008","unstructured":"Freedman, J. E. Oxidative stress and platelets. Arterioscler. Thromb. Vasc. Biol. 28, s11\u2013s16 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1270_CR73","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","volume":"20","author":"M Laforge","year":"2020","unstructured":"Laforge, M. et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat. Rev. Immunol. 20, 515\u2013516 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1270_CR74","doi-asserted-by":"publisher","first-page":"119209","DOI":"10.1016\/j.biomaterials.2019.05.020","volume":"215","author":"T Mei","year":"2019","unstructured":"Mei, T. et al. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment\u2014synergistic effect of thrombolysis and antioxidant. Biomaterials 215, 119209 (2019).","journal-title":"Biomaterials"},{"key":"1270_CR75","unstructured":"Genentech Inc. Efficacy of tocilizumab on patients with COVID-19. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04356937 (2020)."},{"key":"1270_CR76","unstructured":"Simmons, J. Phase 2 trial using rhDNase to reduce mortality in COVID-19 patients with respiratory failure (DAMPENCOVID). ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04445285 (2020)."},{"key":"1270_CR77","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s40265-022-01684-5","volume":"82","author":"YY Syed","year":"2022","unstructured":"Syed, Y. Y. Molnupiravir: first approval. Drugs 82, 455\u2013460 (2022).","journal-title":"Drugs"},{"key":"1270_CR78","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40265-022-01692-5","volume":"82","author":"YN Lamb","year":"2022","unstructured":"Lamb, Y. N. Nirmatrelvir plus ritonavir: first approval. Drugs 82, 585\u2013591 (2022).","journal-title":"Drugs"},{"key":"1270_CR79","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/s41587-021-01085-1","volume":"39","author":"M Peplow","year":"2021","unstructured":"Peplow, M. Nanotechnology offers alternative ways to fight COVID-19 pandemic with antivirals. Nat. Biotechnol. 39, 1172\u20131174 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1270_CR80","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/nano12060990","volume":"12","author":"Q He","year":"2022","unstructured":"He, Q. et al. Antiviral properties of silver nanoparticles against SARS-CoV-2: effects of surface coating and particle size. Nanomaterials 12, 990 (2022).","journal-title":"Nanomaterials"},{"key":"1270_CR81","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bbrc.2020.09.018","volume":"533","author":"SS Jeremiah","year":"2020","unstructured":"Jeremiah, S. S., Miyakawa, K., Morita, T., Yamaoka, Y. & Ryo, A. Potent antiviral effect of silver nanoparticles on SARS-CoV-2. Biochem. Biophys. Res. Commun. 533, 195\u2013200 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1270_CR82","doi-asserted-by":"publisher","first-page":"16465","DOI":"10.1039\/D1NR03745E","volume":"13","author":"L Stagi","year":"2021","unstructured":"Stagi, L. et al. Effective SARS-CoV-2 antiviral activity of hyperbranched polylysine nanopolymers. Nanoscale 13, 16465\u201316476 (2021).","journal-title":"Nanoscale"},{"key":"1270_CR83","doi-asserted-by":"publisher","first-page":"20995","DOI":"10.1021\/acsami.1c02755","volume":"13","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Glycyrrhizic acid nanoparticles as antiviral and anti-inflammatory agents for COVID-19 treatment. ACS Appl. Mater. Interfaces 13, 20995\u201321006 (2021).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"1270_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00926-0","volume":"19","author":"Q Tan","year":"2021","unstructured":"Tan, Q. et al. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. J. Nanobiotechnol. 19, 173 (2021).","journal-title":"J. Nanobiotechnol."},{"key":"1270_CR85","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1021\/acsami.1c19541","volume":"14","author":"X Ma","year":"2022","unstructured":"Ma, X. et al. HACE2-exosome-based nano-bait for concurrent SARS-CoV-2 trapping and antioxidant therapy. ACS Appl. Mater. Interfaces 14, 4882\u20134891 (2022).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"1270_CR86","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.1021\/acsnano.0c06836","volume":"15","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Membrane nanoparticles derived from ACE2-rich cells block SARS-CoV-2 infection. ACS Nano 15, 6340\u20136351 (2021).","journal-title":"ACS Nano"},{"key":"1270_CR87","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41565-021-00923-2","volume":"16","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19. Nat. Nanotechnol. 16, 942\u2013951 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"1270_CR88","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/v13030378","volume":"13","author":"A Peddapalli","year":"2021","unstructured":"Peddapalli, A. et al. Demystifying excess immune response in COVID-19 to reposition an orphan drug for down-regulation of NF-\u03baB: a systematic review. Viruses 13, 378 (2021).","journal-title":"Viruses"},{"key":"1270_CR89","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/pharmaceutics13071077","volume":"13","author":"BB Eedara","year":"2021","unstructured":"Eedara, B. B. et al. Inhalation delivery for the treatment and prevention of COVID-19 infection. Pharmaceutics 13, 1077 (2021).","journal-title":"Pharmaceutics"},{"key":"1270_CR90","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1021\/acsnano.6b08551","volume":"11","author":"MR Miller","year":"2017","unstructured":"Miller, M. R. et al. Inhaled nanoparticles accumulate at sites of vascular disease. ACS Nano 11, 4542\u20134552 (2017).","journal-title":"ACS Nano"},{"key":"1270_CR91","doi-asserted-by":"publisher","first-page":"120389","DOI":"10.1016\/j.biomaterials.2020.120389","volume":"267","author":"YY Lee","year":"2021","unstructured":"Lee, Y. Y. et al. Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm. Biomaterials 267, 120389 (2021).","journal-title":"Biomaterials"},{"key":"1270_CR92","doi-asserted-by":"publisher","first-page":"2001940","DOI":"10.1002\/advs.202001940","volume":"7","author":"HH Park","year":"2020","unstructured":"Park, H. H. et al. Bioinspired DNase-I-coated melanin-like nanospheres for modulation of infection-associated NETosis dysregulation. Adv. Sci. 7, 2001940 (2020).","journal-title":"Adv. Sci."},{"key":"1270_CR93","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bja.2021.10.039","volume":"128","author":"M Alsabani","year":"2022","unstructured":"Alsabani, M. et al. Reduction of NETosis by targeting CXCR1\/2 reduces thrombosis, lung injury, and mortality in experimental human and murine sepsis. Br. J. Anaesth. 128, 283\u2013293 (2022).","journal-title":"Br. J. Anaesth."},{"key":"1270_CR94","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3389\/fimmu.2019.02569","volume":"10","author":"N Beristain-Covarrubias","year":"2019","unstructured":"Beristain-Covarrubias, N. et al. Understanding infection-induced thrombosis: lessons learned from animal models. Front. Immunol. 10, 2569 (2019).","journal-title":"Front. Immunol."},{"key":"1270_CR95","doi-asserted-by":"publisher","first-page":"626553","DOI":"10.3389\/fmicb.2021.626553","volume":"12","author":"S Shou","year":"2021","unstructured":"Shou, S. et al. Animal models for COVID-19: hamsters, mouse, ferret, mink, tree shrew, and non-human primates. Front. Microbiol. 12, 626553 (2021).","journal-title":"Front. Microbiol."},{"key":"1270_CR96","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1126\/science.abb7015","volume":"368","author":"J Shi","year":"2020","unstructured":"Shi, J. et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science 368, 1016\u20131020 (2020).","journal-title":"Science"},{"key":"1270_CR97","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/cvr\/cvy219","volume":"114","author":"I Cicha","year":"2018","unstructured":"Cicha, I. et al. From design to the clinic: practical guidelines for translating cardiovascular nanomedicine. Cardiovasc. Res. 114, 1714\u20131727 (2018).","journal-title":"Cardiovasc. Res."},{"key":"1270_CR98","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1039\/D0BM00818D","volume":"8","author":"S Bai","year":"2020","unstructured":"Bai, S. et al. Multimodal and multifunctional nanoparticles with platelet targeting ability and phase transition efficiency for the molecular imaging and thrombolysis of coronary microthrombi. Biomater. Sci. 8, 5047\u20135060 (2020).","journal-title":"Biomater. Sci."},{"key":"1270_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2019.02.033","volume":"300","author":"Y Huang","year":"2019","unstructured":"Huang, Y. et al. An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy. J. Control. Release 300, 1\u201312 (2019).","journal-title":"J. Control. Release"},{"key":"1270_CR100","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.chembiol.2009.08.012","volume":"16","author":"J S\u00e1nchez-Cort\u00e9s","year":"2009","unstructured":"S\u00e1nchez-Cort\u00e9s, J. & Mrksich, M. The platelet integrin alphaIIbbeta3 binds to the RGD and AGD motifs in fibrinogen. Chem. Biol. 16, 990\u20131000 (2009).","journal-title":"Chem. Biol."},{"key":"1270_CR101","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s11095-013-1011-x","volume":"30","author":"S Absar","year":"2013","unstructured":"Absar, S., Nahar, K., Kwon, Y. M. & Ahsan, F. Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy. Pharm. Res. 30, 1663\u20131676 (2013).","journal-title":"Pharm. Res."},{"key":"1270_CR102","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1021\/acsnano.8b09277","volume":"13","author":"Y Zhong","year":"2019","unstructured":"Zhong, Y. et al. Low-intensity focused ultrasound-responsive phase-transitional nanoparticles for thrombolysis without vascular damage: a synergistic nonpharmaceutical strategy. ACS Nano 13, 3387\u20133403 (2019).","journal-title":"ACS Nano"},{"key":"1270_CR103","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.3390\/ijms21082690","volume":"21","author":"H-A Chen","year":"2020","unstructured":"Chen, H.-A., Ma, Y.-H., Hsu, T.-Y. & Chen, J.-P. Preparation of peptide and recombinant tissue plasminogen activator conjugated poly(lactic-co-glycolic acid) (PLGA) magnetic nanoparticles for dual targeted thrombolytic therapy. Int. J. Mol. Sci. 21, 2690 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1270_CR104","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jconrel.2020.11.034","volume":"329","author":"MP Singh","year":"2021","unstructured":"Singh, M. P. et al. Reprogramming the rapid clearance of thrombolytics by nanoparticle encapsulation and anchoring to circulating red blood cells. J. Control. Release 329, 148\u2013161 (2021).","journal-title":"J. Control. Release"},{"key":"1270_CR105","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1016\/j.jacc.2012.08.1008","volume":"60","author":"H Kawata","year":"2012","unstructured":"Kawata, H. et al. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound. J. Am. Coll. Cardiol. 60, 2550\u20132557 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1270_CR106","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1270_CR107","doi-asserted-by":"publisher","first-page":"e20201129","DOI":"10.1084\/jem.20201129","volume":"217","author":"FP Veras","year":"2020","unstructured":"Veras, F. P. et al. SARS-CoV-2\u2013triggered neutrophil extracellular traps mediate COVID-19 pathology. J. Exp. Med. 217, e20201129 (2020).","journal-title":"J. Exp. Med."},{"key":"1270_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76781-0","volume":"10","author":"A Arcanjo","year":"2020","unstructured":"Arcanjo, A. et al. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19). Sci. Rep. 10, 19630 (2020).","journal-title":"Sci. Rep."},{"key":"1270_CR109","doi-asserted-by":"publisher","first-page":"e150862","DOI":"10.1172\/jci.insight.150862","volume":"6","author":"R Kaiser","year":"2021","unstructured":"Kaiser, R. et al. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19. JCI Insight 6, e150862 (2021).","journal-title":"JCI Insight"},{"key":"1270_CR110","doi-asserted-by":"publisher","first-page":"28336","DOI":"10.1073\/pnas.2018030117","volume":"117","author":"M Wu","year":"2020","unstructured":"Wu, M. et al. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases. Proc. Natl Acad. Sci. USA 117, 28336\u201328343 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1270_CR111","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26, 842\u2013844 (2020).","journal-title":"Nat. Med."},{"key":"1270_CR112","first-page":"e150111","volume":"6","author":"Y Zuo","year":"2021","unstructured":"Zuo, Y. et al. Autoantibodies stabilize neutrophil extracellular traps in COVID-19. JCI Insight 6, e150111 (2021).","journal-title":"JCI Insight"},{"key":"1270_CR113","doi-asserted-by":"publisher","first-page":"103382","DOI":"10.1016\/j.ebiom.2021.103382","volume":"67","author":"H Englert","year":"2021","unstructured":"Englert, H. et al. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation. eBioMedicine 67, 103382 (2021).","journal-title":"eBioMedicine"},{"key":"1270_CR114","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1182\/blood-2011-03-343061","volume":"118","author":"F Semeraro","year":"2011","unstructured":"Semeraro, F. et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 118, 1952\u20131961 (2011).","journal-title":"Blood"},{"key":"1270_CR115","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1378\/chest.128.3.1593","volume":"128","author":"P Girard","year":"2005","unstructured":"Girard, P. et al. Deep venous thrombosis in patients with acute pulmonary embolism: prevalence, risk factors, and clinical significance. Chest 128, 1593\u20131600 (2005).","journal-title":"Chest"},{"key":"1270_CR116","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms, J. et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 46, 1089\u20131098 (2020).","journal-title":"Intensive Care Med."},{"key":"1270_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59526-x","volume":"10","author":"IN Chernysh","year":"2020","unstructured":"Chernysh, I. N. et al. The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli. Sci. Rep. 10, 5112 (2020).","journal-title":"Sci. Rep."},{"key":"1270_CR118","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W-j Guan","year":"2020","unstructured":"Guan, W.-j et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41565-022-01270-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-022-01270-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-022-01270-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T08:00:38Z","timestamp":1701590438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41565-022-01270-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1270"],"URL":"https:\/\/doi.org\/10.1038\/s41565-022-01270-6","relation":{},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"assertion":[{"value":"4 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}